Selective elimination of CD133+cancer stem cells using novel BET/HDAC inhibitor TW09 as therapy for pancreatic ductal adenocarcinoma (PDAC)

被引：0
|
作者：
Tiwary, K. [1 ]
Mader, S. [1 ]
Hauff, S. [1 ]
Valar, A. [1 ]
Ditrich, T. [1 ]
Zhang, X. [2 ]
Kleger, A. [1 ]
Seufferlein, T. [1 ]
Sanz, B., Jr. [3 ]
Siveke, J. [2 ]
Walter, K. [1 ]
Hermann, P. C. [1 ]
机构：
[1] Ulm Univ Hosp, Internal Med 1, Ulm, Germany
[2] Univ Klinikum Essen, Inst Dev Canc Therapeut, Essen, Germany
[3] Univ Autonoma Madrid, Dept Biochem, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 08期
关键词：
D O I：
10.1016/j.annonc.2022.09.093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1411 / S1411
页数：1
相关论文
共 6 条
  • [1] The novel dual BET/HDAC inhibitor TW09 mediates cell death by mitochondrial apoptosis in rhabdomyosarcoma cells
    Laszig, Stephanie
    Boedicker, Cathinka
    Weiser, Tim
    Knapp, Stefan
    Fulda, Simone
    CANCER LETTERS, 2020, 486 : 46 - 57
  • [2] Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis
    Li, Xiaoping
    Zhao, Haojie
    Gu, Jianchun
    Zheng, Leizhen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 12084 - 12092
  • [3] Expression and Clinical Significance of Pancreatic Cancer Stem Cells Markers: CD24, CD44 and CD133 in Pancreatic Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP)
    Malecka-Panas, Ewa
    Wlodarski, Wojciech
    Danilewicz, Marian
    Wagrowska-Danilewicz, Malgorzata
    Hogendorf, Piotr
    Strzelczyk, Janusz
    GASTROENTEROLOGY, 2015, 148 (04) : S394 - S394
  • [4] Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+Cancer Stem Cells in PDAC
    Tegethoff, Jana
    Bischoff, Roland
    Saleh, Sawsan
    Blagojevic, Biljana
    Merz, Karl-Heinz
    Cheng, Xinlai
    MOLECULES, 2017, 22 (09):
  • [5] Coexpression of CD44-Positive/CD133-Positive Cancer Stem Cells and CD204-Positive Tumor-Associated Macrophages Is a Predictor of Survival in Pancreatic Ductal Adenocarcinoma
    Hou, Ya-Chin
    Chao, Ying-Jui
    Tung, Hui-Ling
    Wang, Hao-Chen
    Shan, Yan-Shen
    CANCER, 2014, 120 (17) : 2766 - 2777
  • [6] TARGETING THE CD44 VARIANT ISOFORMS USING A NOVEL CDC-LIKE PROTEIN KINASE INHIBITOR TO IMPROVE THE EFFICACY OF STANDARD-OF-CARE THERAPY FOR PANCREATIC DUCTAL ADENOCARCINOMA
    Resmi, Meenu Priya
    Chakrabarti, Jayati
    Adhikary, Pritha
    Wang, Jiang
    Sohal, Davendra
    Shroff, Rachna
    Ahmad, Syed
    Thorne, Curtis
    Zavros, Yana
    GASTROENTEROLOGY, 2024, 166 (05) : S693 - S693
1